Täby, 2 May, 2016 - Mycronic AB (publ), has received yet another order for a
mask writer, replacing an older system for manufacturing of display photomasks.
The system is scheduled to be delivered to a customer in Asia during the second
half-year, 2017.
Mycronic occupies a unique position as the sole supplier in the world of
equipment for manufacturing of advanced photomasks and has delivered
approximately 70 mask writers for display applications. Approximately half of
these are 10 or more years old. Maintaining these systems is increasingly a
challenge. Some of Mycronic's customers with older mask writers also need to
modernize their production equipment.
Mycronic offers a scalable system, built on the Prexision platform, in exchange
for an older system. This allows customers to increase productivity, while at
the same time securing a long term service solution.
”Our customers continue the exchange of older systems. This order is the third
in 2016 and the sixth since the introduction of the offering. The customer gets
the benefits from a scalable mask writer for continued high productivity,” says
Magnus Råberg, Senior VP & General Manager for business area PG at Mycronic AB.
The price level for a replacement mask writer built on the Prexision platform is
normally in the range of USD 12–16 million depending on the configuration and
type of system traded in.
Contacts at Mycronic:
Magnus Råberg
Sr VP & General Manager PG
Tel: +46 8 638 52 00
magnus.raberg@mycronic.com
Per Ekstedt
CFO
Tel: +46 8 638 52 00
per.ekstedt@mycronic.com
About Mycronic AB
Mycronic AB is a Swedish high-tech company engaged in developing, manufacturing
and marketing of production equipment for the electronics industry. Mycronic
headquarters are located in Täby, north of Stockholm and the Group has
subsidiaries in China, France, Germany, Japan, Singapore, South Korea, the
Netherlands, United Kingdom and the United States. For more information see our
web site at: www.mycronic.com
Mycronic AB (publ) is listed on NASDAQ Stockholm, Mid Cap: MYCR.
The information is of the type that Mycronic is required to disclose under the
Financial Instruments trading Act and/or the Swedish Securities Markets Act. The
information was submitted for publication on 2 May, 2016.
